Healthcare Leaders Hub

🏠Home 📰News 📝Blog 🎬Videos Advertise Login

Your trusted source for pharmaceutical news, expert insights, and healthcare innovation.

💼𝕏 👥▶️

Content

📰News
📝Blog
🎬Videos

Company

🏠Home
🏢About Us
📧Contact

© 2026 PharmaVoice. All rights reserved. Empowering healthcare leaders.

Privacy Policy•Terms of Service

Pharma Tech

Supernus and Indivior merge to create scaled, CNS-focused entity

Aug 4, 2026, 10:57 AM

Read Full Article → Supernus and Indivior merge to create scaled, CNS-focused entity

Supernus and Indivior merge to create scaled, CNS-focused entity

Translate article text

Choose a language and wait for the translated text.

Through this merger, Supernus and Indivior will combine their commercial medicinal portfolios, which span CNS and opioid use disorders (OUDs).

Supernus and Indivior merge to create scaled, CNS-focused entity | PharmaVoice